Journal of Neuro-Oncology

, Volume 118, Issue 2, pp 297–304 | Cite as

Reproductive factors and risk of primary brain tumors in women

  • Gabriella M. Anic
  • Melissa H. Madden
  • L. Burton Nabors
  • Jeffrey J. Olson
  • Renato V. LaRocca
  • Zachary J. Thompson
  • Shitaldas J. Pamnani
  • Peter A. Forsyth
  • Reid C. Thompson
  • Kathleen M. Egan
Clinical Study

Abstract

Gender-specific incidence patterns and the presence of hormonal receptors on tumor cells suggest that sex hormones may play a role in the onset of primary brain tumors. However, epidemiological studies on the relation of hormonal risk factors to the risk of brain tumors have been inconsistent. We examined the role of reproductive factors in the onset of glioma and meningioma in a case–control study conducted in the Southeastern US that included 507 glioma cases, 247 meningioma cases, and 695 community-based and friend controls. Unconditional logistic regression was used to estimate odds ratios (ORs) and 95 % confidence intervals (CI) adjusting for age, race, US state of residence, and education. An older age at menarche was associated with an increased risk of glioma (≥15 vs. ≤12 years: OR 1.65; 95 % CI 1.11–2.45), with a stronger association observed in pre-menopausal (OR 2.22; 95 % CI 1.12–4.39) than post-menopausal (OR 1.55; 95 % CI 0.93–2.58) women. When compared to controls, meningioma cases were more likely to have undergone natural menopause (OR 1.52; 95 % CI 1.04–2.21) whereas glioma cases were less likely to be long term users of oral contraceptives (OR 0.47; 95 % CI 0.33–0.68). Increasing parity was not related to the risk of either tumor. Current findings are consistent with a limited role for hormones in the onset of brain tumors in women. Results contribute to a growing body of evidence that a later age at menarche increases the risk of glioma in women.

Keywords

Glioma Meningioma Reproductive factors Exogenous hormones Menarche 

Supplementary material

11060_2014_1427_MOESM1_ESM.doc (77 kb)
Supplementary material 1 (DOC 77 kb)
11060_2014_1427_MOESM2_ESM.doc (34 kb)
Supplementary material 2 (DOC 33 kb)

References

  1. 1.
    Ostrom QT, Gittleman H, Farah P, Ondracek A, Chen Y, Wolinsky Y, Stroup NE, Kruchko C, Barnholtz-Sloan JS (2013) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006–2010. Neuro Oncol 15(Suppl 2):1–56Google Scholar
  2. 2.
    Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97–109PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, Sabel M, Steinbach JP, Heese O, Reifenberger G et al (2007) Long-term survival with glioblastoma multiforme. Brain 130(Pt 10):2596–2606PubMedCrossRefGoogle Scholar
  4. 4.
    Preston DL, Ron E, Yonehara S, Kobuke T, Fujii H, Kishikawa M, Tokunaga M, Tokuoka S, Mabuchi K (2002) Tumors of the nervous system and pituitary gland associated with atomic bomb radiation exposure. J Natl Cancer Inst 94(20):1555–1563PubMedCrossRefGoogle Scholar
  5. 5.
    Ron E, Modan B, Boice JD Jr, Alfandary E, Stovall M, Chetrit A, Katz L (1988) Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 319(16):1033–1039PubMedCrossRefGoogle Scholar
  6. 6.
    Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B, Simon M, Marie Y, Boisselier B, Delattre JY et al (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41(8):899–904PubMedCrossRefGoogle Scholar
  7. 7.
    Wrensch M, Jenkins RB, Chang JS, Yeh RF, Xiao Y, Decker PA, Ballman KV, Berger M, Buckner JC, Chang S et al (2009) Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 41(8):905–908PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Dobbins SE, Broderick P, Melin B, Feychting M, Johansen C, Andersson U, Brannstrom T, Schramm J, Olver B, Lloyd A et al (2011) Common variation at 10p12.31 near MLLT10 influences meningioma risk. Nat Genet 43(9):825–827PubMedCrossRefGoogle Scholar
  9. 9.
    Gu J, Liu Y, Kyritsis AP, Bondy ML (2009) Molecular epidemiology of primary brain tumors. Neurotherapeutics 6(3):427–435PubMedCrossRefGoogle Scholar
  10. 10.
    CBTRUS (2011) Statistical report: primary brain tumors in the United States, 2004–2007. Central Brain Tumor Registry of the United States. Available at http://www.cbtrus.org/2011-NPCR-SEER/WEB-0407-Report-3-3-2011.pdf
  11. 11.
    Deorah S, Lynch CF, Sibenaller ZA, Ryken TC (2006) Trends in brain cancer incidence and survival in the United States: surveillance, epidemiology, and end results program, 1973 to 2001. Neurosurg Focus 20(4):E1PubMedCrossRefGoogle Scholar
  12. 12.
    McKinley BP, Michalek AM, Fenstermaker RA, Plunkett RJ (2000) The impact of age and sex on the incidence of glial tumors in New York state from 1976 to 1995. J Neurosurg 93(6):932–939PubMedCrossRefGoogle Scholar
  13. 13.
    De Nicola AF, Brocca ME, Pietranera L, Garcia-Segura LM (2012) Neuroprotection and sex steroid hormones: evidence of estradiol-mediated protection in hypertensive encephalopathy. Mini Rev Med Chem 12(11):1081–1089PubMedCrossRefGoogle Scholar
  14. 14.
    Garcia-Segura LM, Azcoitia I, DonCarlos LL (2001) Neuroprotection by estradiol. Prog Neurobiol 63(1):29–60PubMedCrossRefGoogle Scholar
  15. 15.
    Kirches E, Warich-Kirches M (2009) 2-methoxyestradiol as a potential cytostatic drug in gliomas? Anticancer Agents Med Chem 9(1):55–65PubMedCrossRefGoogle Scholar
  16. 16.
    Kang SH, Cho HT, Devi S, Zhang Z, Escuin D, Liang Z, Mao H, Brat DJ, Olson JJ, Simons JW et al (2006) Antitumor effect of 2-methoxyestradiol in a rat orthotopic brain tumor model. Cancer Res 66(24):11991–11997PubMedCrossRefGoogle Scholar
  17. 17.
    Lis A, Ciesielski MJ, Barone TA, Scott BE, Fenstermaker RA, Plunkett RJ (2004) 2-Methoxyestradiol inhibits proliferation of normal and neoplastic glial cells, and induces cell death, in vitro. Cancer Lett 213(1):57–65PubMedCrossRefGoogle Scholar
  18. 18.
    Chamaon K, Stojek J, Kanakis D, Braeuninger S, Kirches E, Krause G, Mawrin C, Dietzmann K (2005) Micromolar concentrations of 2-methoxyestradiol kill glioma cells by an apoptotic mechanism, without destroying their microtubule cytoskeleton. J Neurooncol 72(1):11–16PubMedCrossRefGoogle Scholar
  19. 19.
    Jay JR, MacLaughlin DT, Riley KR, Martuza RL (1985) Modulation of meningioma cell growth by sex steroid hormones in vitro. J Neurosurg 62(5):757–762PubMedCrossRefGoogle Scholar
  20. 20.
    Batistatou A, Stefanou D, Goussia A, Arkoumani E, Papavassiliou AG, Agnantis NJ (2004) Estrogen receptor beta (ERbeta) is expressed in brain astrocytic tumors and declines with dedifferentiation of the neoplasm. J Cancer Res Clin Oncol 130(7):405–410PubMedCrossRefGoogle Scholar
  21. 21.
    Gonzalez-Aguero G, Ondarza R, Gamboa-Dominguez A, Cerbon MA, Camacho-Arroyo I (2001) Progesterone receptor isoforms expression pattern in human astrocytomas. Brain Res Bull 56(1):43–48PubMedCrossRefGoogle Scholar
  22. 22.
    Khalid H, Shibata S, Kishikawa M, Yasunaga A, Iseki M, Hiura T (1997) Immunohistochemical analysis of progesterone receptor and Ki-67 labeling index in astrocytic tumors. Cancer 80(11):2133–2140PubMedCrossRefGoogle Scholar
  23. 23.
    Korhonen K, Salminen T, Raitanen J, Auvinen A, Isola J, Haapasalo H (2006) Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression. J Neurooncol 80(1):1–7PubMedCrossRefGoogle Scholar
  24. 24.
    Blankenstein MA, Verheijen FM, Jacobs JM, Donker TH, van Duijnhoven MW, Thijssen JH (2000) Occurrence, regulation, and significance of progesterone receptors in human meningioma. Steroids 65(10–11):795–800PubMedCrossRefGoogle Scholar
  25. 25.
    Khalid H (1994) Immunohistochemical study of estrogen receptor-related antigen, progesterone and estrogen receptors in human intracranial meningiomas. Cancer 74(2):679–685PubMedCrossRefGoogle Scholar
  26. 26.
    Claus EB, Calvocoressi L, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M (2011) Family and personal medical history and risk of meningioma. J Neurosurg 115(6):1072–1077PubMedCentralPubMedCrossRefGoogle Scholar
  27. 27.
    Rao G, Giordano SH, Liu J, McCutcheon IE (2009) The association of breast cancer and meningioma in men and women. Neurosurgery 65(3):483–489 discussion 489Google Scholar
  28. 28.
    Custer BS, Koepsell TD, Mueller BA (2002) The association between breast carcinoma and meningioma in women. Cancer 94(6):1626–1635PubMedCrossRefGoogle Scholar
  29. 29.
    Cowppli-Bony A, Bouvier G, Rue M, Loiseau H, Vital A, Lebailly P, Fabbro-Peray P, Baldi I (2011) Brain tumors and hormonal factors: review of the epidemiological literature. Cancer Causes Control 22(5):697–714PubMedCrossRefGoogle Scholar
  30. 30.
    Little RB, Madden MH, Thompson RC, Olson JJ, Larocca RV, Pan E, Browning JE, Egan KM, Nabors LB (2013) Anthropometric factors in relation to risk of glioma. Cancer Causes Control 24(5):1025–1031PubMedCentralPubMedCrossRefGoogle Scholar
  31. 31.
    Qi ZY, Shao C, Zhang X, Hui GZ, Wang Z (2013) Exogenous and endogenous hormones in relation to glioma in women: a meta-analysis of 11 case-control studies. PLoS ONE 8(7):e68695PubMedCentralPubMedCrossRefGoogle Scholar
  32. 32.
    Kabat GC, Park Y, Hollenbeck AR, Schatzkin A, Rohan TE (2011) Reproductive factors and exogenous hormone use and risk of adult glioma in women in the NIH-AARP Diet and Health Study. Int J Cancer 128(4):944–950PubMedCentralPubMedCrossRefGoogle Scholar
  33. 33.
    Silvera SA, Miller AB, Rohan TE (2006) Hormonal and reproductive factors and risk of glioma: a prospective cohort study. Int J Cancer 118(5):1321–1324PubMedCrossRefGoogle Scholar
  34. 34.
    Onland-Moret NC, Peeters PH, van Gils CH, Clavel-Chapelon F, Key T, Tjonneland A, Trichopoulou A, Kaaks R, Manjer J, Panico S et al (2005) Age at menarche in relation to adult height: the EPIC study. Am J Epidemiol 162(7):623–632PubMedCrossRefGoogle Scholar
  35. 35.
    Juul A, Bang P, Hertel NT, Main K, Dalgaard P, Jorgensen K, Muller J, Hall K, Skakkebaek NE (1994) Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 78(3):744–752PubMedGoogle Scholar
  36. 36.
    Kitahara CM, Wang SS, Melin BS, Wang Z, Braganza M, Inskip PD, Albanes D, Andersson U, Beane Freeman LE, Buring JE, et al (2012) Association between adult height, genetic susceptibility and risk of glioma. Int J Epidemiol 41(4):1075–1085Google Scholar
  37. 37.
    Jhawar BS, Fuchs CS, Colditz GA, Stampfer MJ (2003) Sex steroid hormone exposures and risk for meningioma. J Neurosurg 99(5):848–853PubMedCrossRefGoogle Scholar
  38. 38.
    Claus EB, Calvocoressi L, Bondy ML, Wrensch M, Wiemels JL, Schildkraut JM (2013) Exogenous hormone use, reproductive factors, and risk of intracranial meningioma in females. J Neurosurg 118(3):649–656PubMedCentralPubMedCrossRefGoogle Scholar
  39. 39.
    Korhonen K, Raitanen J, Isola J, Haapasalo H, Salminen T, Auvinen A (2010) Exogenous sex hormone use and risk of meningioma: a population-based case-control study in Finland. Cancer Causes Control 21(12):2149–2156PubMedCrossRefGoogle Scholar
  40. 40.
    Johnson DR, Olson JE, Vierkant RA, Hammack JE, Wang AH, Folsom AR, Virnig BA, Cerhan JR (2011) Risk factors for meningioma in postmenopausal women: results from the Iowa women’s health study. Neuro Oncol 13(9):1011–1019PubMedCentralPubMedCrossRefGoogle Scholar
  41. 41.
    Michaud DS, Gallo V, Schlehofer B, Tjonneland A, Olsen A, Overvad K, Dahm CC, Kaaks R, Lukanova A, Boeing H et al (2010) Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study. Cancer Epidemiol Biomarkers Prev 19(10):2562–2569PubMedCentralPubMedCrossRefGoogle Scholar
  42. 42.
    Wigertz A, Lonn S, Hall P, Auvinen A, Christensen HC, Johansen C, Klaeboe L, Salminen T, Schoemaker MJ, Swerdlow AJ et al (2008) Reproductive factors and risk of meningioma and glioma. Cancer Epidemiol Biomarkers Prev 17(10):2663–2670PubMedCrossRefGoogle Scholar
  43. 43.
    Custer B, Longstreth WT Jr, Phillips LE, Koepsell TD, Van Belle G (2006) Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study. BMC Cancer 6:152PubMedCentralPubMedCrossRefGoogle Scholar
  44. 44.
    Lee E, Grutsch J, Persky V, Glick R, Mendes J, Davis F (2006) Association of meningioma with reproductive factors. Int J Cancer 119(5):1152–1157PubMedCrossRefGoogle Scholar
  45. 45.
    Hatch EE, Linet MS, Zhang J, Fine HA, Shapiro WR, Selker RG, Black PM, Inskip PD (2005) Reproductive and hormonal factors and risk of brain tumors in adult females. Int J Cancer 114(5):797–805PubMedCrossRefGoogle Scholar
  46. 46.
    Schlehofer B, Blettner M, Preston-Martin S, Niehoff D, Wahrendorf J, Arslan A, Ahlbom A, Choi WN, Giles GG, Howe GR et al (1999) Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer 82(2):155–160PubMedCrossRefGoogle Scholar
  47. 47.
    Felini MJ, Olshan AF, Schroeder JC, Carozza SE, Miike R, Rice T, Wrensch M (2009) Reproductive factors and hormone use and risk of adult gliomas. Cancer Causes Control 20(1):87–96PubMedCentralPubMedCrossRefGoogle Scholar
  48. 48.
    Schlehofer B, Blettner M, Becker N, Martinsohn C, Wahrendorf J (1992) Medical risk factors and the development of brain tumors. Cancer 69(10):2541–2547PubMedCrossRefGoogle Scholar
  49. 49.
    Cicuttini FM, Hurley SF, Forbes A, Donnan GA, Salzberg M, Giles GG, McNeil JJ (1997) Association of adult glioma with medical conditions, family and reproductive history. Int J Cancer 71(2):203–207PubMedCrossRefGoogle Scholar
  50. 50.
    Huang K, Whelan EA, Ruder AM, Ward EM, Deddens JA, Davis-King KE, Carreon T, Waters MA, Butler MA, Calvert GM et al (2004) Reproductive factors and risk of glioma in women. Cancer Epidemiol Biomarkers Prev 13(10):1583–1588PubMedGoogle Scholar
  51. 51.
    Benson VS, Pirie K, Green J, Casabonne D, Beral V (2008) Lifestyle factors and primary glioma and meningioma tumours in the million women study cohort. Br J Cancer 99(1):185–190PubMedCentralPubMedCrossRefGoogle Scholar
  52. 52.
    Schlehofer B, Blettner M, Wahrendorf J (1992) Association between brain tumors and menopausal status. J Natl Cancer Inst 84(17):1346–1349PubMedCrossRefGoogle Scholar
  53. 53.
    Lambe M, Coogan P, Baron J (1997) Reproductive factors and the risk of brain tumors: a population-based study in Sweden. Int J Cancer 72(3):389–393PubMedCrossRefGoogle Scholar
  54. 54.
    Wang SS, Hartge P, Yeager M, Carreon T, Ruder AM, Linet M, Inskip PD, Black A, Hsing AW, Alavanja M et al (2011) Joint associations between genetic variants and reproductive factors in glioma risk among women. Am J Epidemiol 174(8):901–908PubMedCentralPubMedCrossRefGoogle Scholar
  55. 55.
    Wigertz A, Lonn S, Mathiesen T, Ahlbom A, Hall P, Feychting M (2006) Risk of brain tumors associated with exposure to exogenous female sex hormones. Am J Epidemiol 164(7):629–636PubMedCrossRefGoogle Scholar
  56. 56.
    Cea-Soriano L, Blenk T, Wallander MA, Rodriguez LA (2012) Hormonal therapies and meningioma: is there a link? Cancer Epidemiol 36(2):198–205PubMedCrossRefGoogle Scholar
  57. 57.
    Michels KB, Manson JE (2003) Postmenopausal hormone therapy: a reversal of fortune. Circulation 107(14):1830–1833PubMedCrossRefGoogle Scholar
  58. 58.
    Wacholder S, Silverman DT, McLaughlin JK, Mandel JS (1992) Selection of controls in case-control studies. II. Types of controls. Am J Epidemiol 135(9):1029–1041PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Gabriella M. Anic
    • 1
  • Melissa H. Madden
    • 1
  • L. Burton Nabors
    • 2
  • Jeffrey J. Olson
    • 3
  • Renato V. LaRocca
    • 4
  • Zachary J. Thompson
    • 5
  • Shitaldas J. Pamnani
    • 1
  • Peter A. Forsyth
    • 6
  • Reid C. Thompson
    • 7
  • Kathleen M. Egan
    • 1
  1. 1.Department of Cancer EpidemiologyH. Lee Moffitt Cancer Center & Research InstituteTampaUSA
  2. 2.Neuro-oncology ProgramUniversity of Alabama at BirminghamBirminghamUSA
  3. 3.Department of NeurosurgeryEmory School of MedicineAtlantaUSA
  4. 4.Norton Cancer InstituteLouisvilleUSA
  5. 5.Biostatistics and Bioinformatics DepartmentH. Lee Moffitt Cancer Center & Research InstituteTampaUSA
  6. 6.Department of NeurooncologyH. Lee Moffitt Cancer Center & Research InstituteTampaUSA
  7. 7.Department of Neurological SurgeryVanderbilt University Medical CenterNashvilleUSA

Personalised recommendations